RG002-03
Recurrent Respiratory Papillomatosis (RRP) / Condyloma Acuminatum
PreclinicalActive
Key Facts
Indication
Recurrent Respiratory Papillomatosis (RRP) / Condyloma Acuminatum
Phase
Preclinical
Status
Active
Company
About RinuaGene Biotechnology
A clinical-stage biotech developing mRNA therapeutics and vaccines with a proprietary platform, targeting HPV-related diseases, rare conditions, and infectious diseases.
View full company profile